SCHEMBL375311

SCHEMBL375311

N#Cc1cccc(CNC2CCOCC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.53
KDM1A O60341 1/20 0.53
MAOB P27338 1/20 0.53
PDCD1 Q15116 2/20 0.49
CD274 Q9NZQ7 2/20 0.49
PDE2A O00408 1/20 0.49
MAPK1 P28482 1/20 0.48
JAK1 P23458 1/20 0.46
MAP4K4 O95819 1/20 0.44
EGLN2 Q96KS0 1/20 0.43
ALDH1A1 P00352 1/20 0.43
PDE1A P54750 1/20 0.42
PDE1C Q14123 1/20 0.42
CCR2 P41597 1/20 0.41
PRKD1 Q15139 1/20 0.41
VNN1 O95497 1/20 0.41
SLC6A4 P31645 1/20 0.41
VCP P55072 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19650829 0.90 MAOA (0.59) MAOAKDM1AMAOBJAK1EGLN2
SCHEMBL30471950 0.90 MAOA (0.59) MAOAKDM1AMAOBJAK1EGLN2
SCHEMBL24093253 0.85 KDM1A (0.56) MAOAKDM1AMAOBJAK1ALDH1A1
SCHEMBL28081753 0.84 KDM1A (0.54) MAOAKDM1AMAOBJAK1ALDH1A1
SCHEMBL24093405 0.83 MAOA (0.53) MAOAKDM1AMAOBJAK1EGLN2
SCHEMBL15014610 0.83 MAOA (0.53) MAOAKDM1AMAOBJAK1EGLN2
SCHEMBL24092988 0.81 MAOA (0.51) MAOAKDM1AMAOBJAK1EGLN2
SCHEMBL19568086 0.81 MAOA (0.51) MAOAKDM1AMAOBJAK1EGLN2
SCHEMBL12424954 0.78 MAOA (0.58) MAOAKDM1AMAOBPDE2AJAK1
SCHEMBL17308302 0.78 ALDH1A1 (0.49) PDCD1CD274MAP4K4ALDH1A1PRKD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 MAOA 325/4885KDM1A 4445/4885MAOB 205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.